SCM
TNDM icon

Suffolk Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Suffolk Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$390K Buy
+10,272
New +$363K 0.07% 68
2018
Q3 		– Sell
-36,785
Closed -$810K – 144
2018
Q2 		$810K Buy
+36,785
New +$452K 0.12% 87

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Suffolk Capital Management's TNDM Position: Q4 2018 in Review

Suffolk Capital Management opened a new position in Tandem Diabetes Care (TNDM) in Q4 2018: 10,272 shares worth $390K. The stake represents 0.07% of the portfolio and ranks #68 among its holdings. This is a return to the name: Suffolk Capital Management previously reported a position in TNDM as recently as Q2 2018.

Suffolk Capital Management first reported a position in TNDM in Q2 2018 and has held it in 2 quarters since. The position peaked at $810K in Q2 2018. 200 funds tracked by Wall St. Rank hold TNDM as of Q4 2018.

  • Suffolk Capital Management held 10,272 shares of Tandem Diabetes Care worth $390K as of Q4 2018.
  • Tandem Diabetes Care was a new Suffolk Capital Management position in Q4 2018.
  • Tandem Diabetes Care made up 0.07% of Suffolk Capital Management's portfolio in Q4 2018, its #68 holding.
  • Suffolk Capital Management first reported a position in Tandem Diabetes Care in Q2 2018 and has held it in 2 quarters since.
  • Suffolk Capital Management's Tandem Diabetes Care position peaked at $810K in Q2 2018.
  • 200 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2018.

Based on Suffolk Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.